3 research outputs found

    Performance Characteristics of Adenoid Cystic Carcinoma of the Salivary Glands in Fine-Needle Aspirates Results From the College of American Pathologists Nongynecologic Cytology Program

    No full text
    Context.-Although the cytomorphology of adenoid cystic carcinoma (ACC) has been well described, the accuracy of this diagnosis in fine-needle aspirates (FNAs) of the salivary glands has not been extensively evaluated. Objective.-To assess participants\u27 responses in the College of American Pathologists (CAP) Nongynecologic Cytology (NGC) Program to determine the accuracy and false-negative rate of ACC cases in salivary gland FNAs. Design.-A retrospective review of the CAP NGC Program\u27s cumulative data from 2000-2010 was performed for the general and the specific reference diagnosis categories for ACC in salivary gland FNAs according to preparation and participant types. Results.-Of 5156 responses, the overall concordance rates for both the general category of malignancy and the specific category of ACC were 63.6% (3279 of 5156) and 38.6% (1966 of 5088), respectively, with a false-negative rate of 36.4% (1877 of 5156). The most frequent false-negative responses were pleomorphic (1080) and monomorphic (526) adenoma (1614 of 5088, 31.5%), while lymphoma was the most frequent malignant misinterpretation. There was a significant statistical difference in concordance to the reference interpretation between the reader types: 39.9% (1006 of 2521) concordance rate for pathologists compared to 33.8% (503 of 1488) for cytotechnologists. However, there was no significant statistical difference for concordance to the general category or reference interpretation, based on preparation type (Papanicolaou versus modified Giemsa stained). Conclusions.-In this interlaboratory comparison educational program, accurate identification of ACC has shown to be problematic, with ACC representing an important cause of false-negative responses. The most common diagnostic pitfall is distinguishing this entity from pleomorphic and monomorphic adenoma in the benign category and from lymphoma and adenocarcinoma in the malignant one

    The Milan System for Reporting Salivary Gland Cytopathology: Analysis and suggestions of initial survey

    No full text
    BACKGROUND: An international panel of experts in the field of salivary gland cytology (SGC), supported by the American Society of Cytopathology (ASC) and the International Academy of Cytology, conducted a survey to seek evidence and practice patterns regarding SGC. Results were used to provide focus for the proposed Milan System for Reporting Salivary Gland Cytopathology. METHODS: The study group, formed during the 2015 European Congress of Cytology held in Milan, Italy, generated a survey that included 49 specific questions related to the taxonomies, practices, and diagnostic entities of salivary cytology. Qualtrics software was used as the study platform. Software and server support were provided by the division of information technology at the University of Wisconsin. The survey was available online from November 2015 until February 2016. Participants were invited through the Web sites of the ASC, the International Academy of Cytology, and the Papanicolaou Society of Cytopathology as well as by the ASC e-mail \u201cListServe\u201d; responses were evaluated by the Milan System editors. RESULTS: Responses from a total of 515 participants were collected and reviewed. A total of 347 participants provided demographic data information. Responses revealed variations in diagnostic practice and subsequent management. Participants believed that the acceptable rate for nondiagnostic samples should not be higher than 10%. There were varied opinions regarding the approach to neoplastic lesions of uncertain malignant potential, those that may or may have not local invasion and distant spread. CONCLUSIONS: Results of the survey demonstrated strong support for the development of a unified system for reporting SGC. Cancer Cytopathol 2017;125:757-66. \ua9 2017 American Cancer Society

    Chromosomal damage as prognosis marker in cervical carcinogenesis

    No full text
    Cancer of the uterine cervix is the third most common cancer in women worldwide and the most common cancer among Mexican and Latin American women. Risk factors that have been associated with the development of cervical intraepithelial neoplasia suggest that Human Papillomavirus (HPV) types 16, 18, 31, and 33 entail a high risk of developing a malignancy of this type. The accumulation of genetic alterations allows the growth of neoplastic cells; chromosomal instability is an event that occurs in the precancerous stages. The candidate cancer risk biomarkers include cytogenetic endpoints, such as chromosomal aberrations, sister chromatid exchange, micronuclei, and the outcomes of comet assay and DNA breakage detection-fluorescence in situ hybridization. The patterns identified in these cytogenetic studies indicate that chromosomal instability is a transient and chromosomally unstable intermediate in the development of cervical lesions. In this context, the mechanisms that may underlie the progressive increase in genetic instability in these patients seem to be related directly to HPV infection. The studies discussed in this paper show that chromosomal instability may serve as a biomarker by predicting the progression of cervical intraepithelial neoplasia. Nevertheless, these results should be validated in larger, prospective studies.Π Π°ΠΊ шСйки ΠΌΠ°Ρ‚ΠΊΠΈ являСтся Ρ‚Ρ€Π΅Ρ‚ΡŒΠΈΠΌ ΠΏΠΎ распространСнности Π² ΠΌΠΈΡ€Π΅ Ρ‚ΠΈΠΏΠΎΠ² Ρ€Π°ΠΊΠ° Ρƒ ΠΆΠ΅Π½Ρ‰ΠΈΠ½ ΠΈ Π½Π°ΠΈΠ±ΠΎΠ»Π΅Π΅ часто Π²ΡΡ‚Ρ€Π΅Ρ‡Π°ΡŽΡ‰ΠΈΠΌΡΡ Ρƒ ΠΆΠ΅Π½Ρ‰ΠΈΠ½ МСксики ΠΈ Латинской АмСрики. Π€Π°ΠΊΡ‚ΠΎΡ€Ρ‹ риска, связанныС с Ρ€Π°Π·Π²ΠΈΡ‚ΠΈΠ΅ΠΌ ΠΈΠ½Ρ‚Ρ€Π°ΡΠΏΠΈΡ‚Π΅Π»ΠΈΠ°Π»ΡŒΠ½ΠΎΠΉ Ρ†Π΅Ρ€Π²ΠΈΠΊΠ°Π»ΡŒΠ½ΠΎΠΉ Π½Π΅ΠΎΠΏΠ»Π°Π·ΠΈΠΈ, ΠΏΡ€Π΅Π΄ΠΏΠΎΠ»Π°Π³Π°ΡŽΡ‚, Ρ‡Ρ‚ΠΎ папилломавирус Ρ‡Π΅Π»ΠΎΠ²Π΅ΠΊΠ° (HPV) Ρ‚ΠΈΠΏΠΎΠ² 16, 18, 31 ΠΈ 33 Π²Π»Π΅Ρ‡Π΅Ρ‚ Π·Π° собой высокий риск развития ΠΎΠΏΡƒΡ…ΠΎΠ»Π΅ΠΉ этого Ρ‚ΠΈΠΏΠ°. НакоплСниС гСнСтичСских ΠΈΠ·ΠΌΠ΅Π½Π΅Π½ΠΈΠΉ Π΄Π΅Π»Π°Π΅Ρ‚ Π²ΠΎΠ·ΠΌΠΎΠΆΠ½Ρ‹ΠΌ рост ΠΎΠΏΡƒΡ…ΠΎΠ»Π΅Π²Ρ‹Ρ… ΠΊΠ»Π΅Ρ‚ΠΎΠΊ, хромосомная Π½Π΅ΡΡ‚Π°Π±ΠΈΠ»ΡŒΠ½ΠΎΡΡ‚ΡŒ являСтся событиСм, ΠΊΠΎΡ‚ΠΎΡ€ΠΎΠ΅ ΠΏΡ€Π΅Π΄ΡˆΠ΅ΡΡ‚Π²ΡƒΠ΅Ρ‚ ΠΏΡ€Π΅Π΄Ρ€Π°ΠΊΠΎΠ²Ρ‹ΠΌ стадиям. Π’ΠΎΠ·ΠΌΠΎΠΆΠ½Ρ‹Π΅ Π±ΠΈΠΎΠΌΠ°Ρ€ΠΊΠ΅Ρ€Ρ‹ риска ΠΎΠΏΡƒΡ…ΠΎΠ»ΠΈ Π²ΠΊΠ»ΡŽΡ‡Π°ΡŽΡ‚ цитогСнСтичСскиС ΠΊΡ€ΠΈΡ‚Π΅Ρ€ΠΈΠΈ, Ρ‚Π°ΠΊΠΈΠ΅ ΠΊΠ°ΠΊ хромосомныС Π°Π±Π΅Ρ€Ρ€Π°Ρ†ΠΈΠΈ, ΠΎΠ±ΠΌΠ΅Π½ сСстринских Ρ…Ρ€ΠΎΠΌΠ°Ρ‚ΠΈΠ΄, микроядра, ΠΈ Π·Π°ΠΊΠ°Π½Ρ‡ΠΈΠ²Π°ΡŽΡ‚ΡΡ Comet-Π°Π½Π°Π»ΠΈΠ·ΠΎΠΌ ΠΈ Π΄Π΅Ρ‚Π΅ΠΊΡ†ΠΈΠ΅ΠΉ ΠΏΠΎΠ»ΠΎΠΌΠΎΠΊ Π”ΠΠš с ΠΏΠΎΠΌΠΎΡ‰ΡŒΡŽ Ρ„Π»ΡŽΠΎΡ€Π΅ΡΡ†Π΅Π½Ρ‚Π½ΠΎΠΉ Π³ΠΈΠ±Ρ€ΠΈΠ΄ΠΈΠ·Π°Ρ†ΠΈΠΈ in situ. ΠžΠ±Ρ€Π°Π·Ρ†Ρ‹, ΠΈΠ΄Π΅Π½Ρ‚ΠΈΡ„ΠΈΡ†ΠΈΡ€ΠΎΠ²Π°Π½Π½Ρ‹Π΅ Π² Ρ‚Π°ΠΊΠΈΡ… цитогСнСтичСских исслСдованиях, ΠΏΠΎΠΊΠ°Π·Ρ‹Π²Π°ΡŽΡ‚, Ρ‡Ρ‚ΠΎ хромосомная Π½Π΅ΡΡ‚Π°Π±ΠΈΠ»ΡŒΠ½ΠΎΡΡ‚ΡŒ являСтся Ρ‚Ρ€Π°Π½Π·ΠΈΠ΅Π½Ρ‚Π½Ρ‹ΠΌ ΠΏΡ€ΠΎΠΌΠ΅ΠΆΡƒΡ‚ΠΎΡ‡Π½Ρ‹ΠΌ Π·Π²Π΅Π½ΠΎΠΌ Π² Ρ€Π°Π·Π²ΠΈΡ‚ΠΈΠΈ Ρ†Π΅Ρ€Π²ΠΈΠΊΠ°Π»ΡŒΠ½Ρ‹Ρ… Π½Π°Ρ€ΡƒΡˆΠ΅Π½ΠΈΠΉ. Π’ этой связи ΠΌΠ΅Ρ…Π°Π½ΠΈΠ·ΠΌΡ‹, ΠΊΠΎΡ‚ΠΎΡ€Ρ‹Π΅ ΠΌΠΎΠ³ΡƒΡ‚ Π»Π΅ΠΆΠ°Ρ‚ΡŒ Π² основС ΠΏΡ€ΠΎΠ³Ρ€Π΅ΡΡΠΈΡ€ΡƒΡŽΡ‰Π΅ΠΉ гСнСтичСской Π½Π΅ΡΡ‚Π°Π±ΠΈΠ»ΡŒΠ½ΠΎΡΡ‚ΠΈ Ρƒ Ρ‚Π°ΠΊΠΈΡ… ΠΏΠ°Ρ†ΠΈΠ΅Π½Ρ‚ΠΎΠ², каТутся нСпосрСдствСнно связанными с ΠΈΠ½Ρ„Π΅ΠΊΡ†ΠΈΠ΅ΠΉ HPV. НастоящСС исслСдованиС ΠΏΠΎΠΊΠ°Π·Ρ‹Π²Π°Π΅Ρ‚, Ρ‡Ρ‚ΠΎ хромосомная Π½Π΅ΡΡ‚Π°Π±ΠΈΠ»ΡŒΠ½ΠΎΡΡ‚ΡŒ ΠΌΠΎΠΆΠ΅Ρ‚ ΡΠ»ΡƒΠΆΠΈΡ‚ΡŒ Π±ΠΈΠΎΠΌΠ°Ρ€ΠΊΠ΅Ρ€ΠΎΠΌ для прСдсказания развития ΠΈΠ½Ρ‚Ρ€Π°ΡΠΏΠΈΡ‚Π΅Π»ΠΈΠ°Π»ΡŒΠ½ΠΎΠΉ Ρ†Π΅Ρ€Π²ΠΈΠΊΠ°Π»ΡŒΠ½ΠΎΠΉ Π½Π΅ΠΎΠΏΠ»Π°Π·ΠΈΠΈ, Ρ‚Π΅ΠΌ Π½Π΅ ΠΌΠ΅Π½Π΅Π΅ эти Ρ€Π΅Π·ΡƒΠ»ΡŒΡ‚Π°Ρ‚Ρ‹ Π΄ΠΎΠ»ΠΆΠ½Ρ‹ Π±Ρ‹Ρ‚ΡŒ ΠΎΡ†Π΅Π½Π΅Π½Ρ‹ Π² Π±ΠΎΠ»Π΅Π΅ ΠΌΠ°ΡΡˆΡ‚Π°Π±Π½Ρ‹Ρ… исслСдованиях
    corecore